Advances in Addressing Patient Heterogeneity in Economic Evaluation: A Review of the Methods Literature-Reference-Cited by-同舟云学术

Advances in Addressing Patient Heterogeneity in Economic Evaluation: A Review of the Methods Literature

Published:2024-04-27 Issue:7 Volume:42 Page:737-749
ISSN:1170-7690
Container-title:PharmacoEconomics
language:en
Short-container-title:PharmacoEconomics

Author:

Shields Gemma E.^ORCID,Clarkson Paul^ORCID,Bullement Ash^ORCID,Stevens Warren^ORCID,Wilberforce Mark^ORCID,Farragher Tracey^ORCID,Verma Arpana^ORCID,Davies Linda M.^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40273-024-01377-9.pdf

Reference81 articles.

1. Grutters JPC, Sculpher M, Briggs AH, Severens JL, Candel MJ, Stahl JE, De Ruysscher D, Boer A, Ramaekers BLT, Joore MA. Acknowledging patient heterogeneity in economic evaluation. Pharmacoeconomics. 2013;31:111–23. https://doi.org/10.1007/s40273-012-0015-4.

2. Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. Oxford: Oxford University Press; 2006.

3. Ramaekers BLT, Joore MA, Grutters JPC. How should we deal with patient heterogeneity in economic evaluation: a systematic review of national pharmacoeconomic guidelines. Value Health. 2013;16:855–62. https://doi.org/10.1016/J.JVAL.2013.02.013.

4. Espinoza MA, Sculpher MJ, Manca A, Basu A. Analysing heterogeneity to support decision making. In: Encyclopedia of Health Economics. Elsevier; 2004. p. 71–6.

5. Varadhan R, Seeger JD, et al. Estimation and reporting of heterogeneity of treatment effects. In: Velentgas P, Dreyer NA, Nourjah P, et al., editors. Developing a protocol for observational comparative effectiveness research: a user’s guide. Rockville: Agency for Healthcare Research and Quality; 2013.